Discuss This Disease

4 free views remaining today

trophoblastic neoplasm

Description

Gestational Trophoblastic Neoplasia (GTN): A Rare and Potentially Malignant Condition

Gestational trophoblastic neoplasia (GTN) is a rare and potentially malignant condition that arises from the abnormal growth of trophoblast cells in the uterus. These cells are normally responsible for forming the placenta during pregnancy.

Characteristics of GTN

  • GTN can be classified into benign and malignant lesions.
  • Benign lesions include placental site nodule and hydatidiform moles, while malignant lesions have four subtypes:
    • Invasive mole
    • Choriocarcinoma
    • Placental site trophoblastic tumor (PSTT)
    • Epithelioid trophoblastic tumor (ETT) [2]
  • GTN can invade locally or metastasize, making it a serious condition that requires prompt medical attention. [4]

Symptoms of GTN

  • Abnormal vaginal bleeding
  • Missed periods
  • Pelvic pain

Treatment and Management

  • Treatment for GTN typically involves suction curettage to evacuate the tumor.
  • In some cases, hysterectomy may be recommended if childbearing is not planned.
  • A chest x-ray and serial measurements of serum beta-hCG are also used to monitor the condition. [12]

**

Additional Characteristics

  • Pelvic pain
  • Missed periods
  • Abnormal vaginal bleeding
  • Suction curettage to evacuate the tumor
  • Hysterectomy if childbearing is not planned
  • Chest x-ray and serial measurements of serum beta-hCG

Signs and Symptoms

Common Signs and Symptoms of Gestational Trophoblastic Neoplasia (GTN)

Gestational trophoblastic neoplasia (GTN) is a rare type of cancer that develops in the uterus during pregnancy. The symptoms of GTN can be similar to those experienced during a normal pregnancy, making it challenging to diagnose. However, there are some key signs and symptoms to look out for:

  • Vaginal bleeding: This is one of the most common symptoms of GTN, and it can occur at any stage of pregnancy. The bleeding may be bright red or watery brown in color.
  • Abdominal pain: Some women with GTN may experience pelvic pain or pressure in the abdomen.
  • Missed menstrual periods: Women who are experiencing a molar pregnancy (a type of GTN) may not have their usual menstrual period.
  • A larger-than-expected uterus: In some cases, the uterus may be larger than expected during pregnancy.

Other Possible Symptoms

In addition to these common symptoms, some women with GTN may experience:

  • High blood pressure
  • Low red blood cell count (anemia)
  • Severe nausea and vomiting during pregnancy

It's essential to note that these symptoms can also be caused by other conditions, so a proper diagnosis from a healthcare professional is crucial.

References:

  • [1] Symptoms listed above are associated with many other gynecologic and pregnancy-related conditions. However, the only way to know if your symptoms are being caused by GTN is to consult with your doctor (Source: #4)
  • [2] Vaginal bleeding not related to menstruation, a uterus that is larger than expected during pregnancy, pain or pressure in the pelvis are all possible symptoms of GTN (Source: #5 and #7)
  • [3] Symptoms of GTD include vaginal bleeding, swelling of the abdomen, and ovarian cysts (Source: #8)

Additional Symptoms

  • Low red blood cell count (anemia)
  • Vaginal bleeding
  • Severe nausea and vomiting during pregnancy
  • Missed menstrual periods
  • A larger-than-expected uterus
  • high blood pressure
  • abdominal pain

Diagnostic Tests

Diagnostic Tests for Trophoblastic Neoplasms

The diagnosis of gestational trophoblastic neoplasia (GTN) involves a combination of medical history, physical examination, and various diagnostic tests. The following are some of the key diagnostic tests used to diagnose GTN:

  • Pelvic exam: A pelvic exam is performed to feel the size, shape, and position of the uterus and ovaries.
  • Ultrasound: An ultrasound exam of the pelvis may be performed to visualize the uterus and detect any abnormalities.
  • Blood tests: Blood tests are used to check for levels of human chorionic gonadotropin (hCG), a hormone produced during pregnancy. Elevated hCG levels can indicate GTN [8][9].
  • CA-125 blood test: A CA-125 blood test may be performed to determine if a tumor is present in the body.
  • Serum tumor marker test: A serum tumor marker test measures the amount of beta human chorionic gonadotropin (β-hCG) in the body, which can indicate GTN [12].
  • Dilation and curettage (D and C): A D and C may be performed to collect tissue samples from the uterus for further examination.
  • Examination of the placenta: The placenta may be examined to determine if it is abnormal or contains any tumors.

These diagnostic tests are essential in identifying GTN and determining its stage, which is crucial in planning the appropriate treatment [7].

References:

[7] - Important parts of the diagnosis include: Pelvic examination; Blood tests; Pelvic ultrasound; Dilation and curettage (D and C); Examination of the placenta.

[8] - A blood test to determine if a tumor is present in your body. Serum tumor marker test: A blood test to measure the amount of beta human chorionic gonadotropin (β-hCG) in the body.

[9] - A blood test to check for levels of human chorionic gonadotropin (hCG),

Treatment

Treatment Options for Trophoblastic Neoplasms

Trophoblastic neoplasms, a type of cancer that arises from placental tissue, can be treated with various medications depending on the specific type and risk category. The treatment options include:

  • Chemotherapy: This is the most common treatment for trophoblastic neoplasms, especially for high-risk cases. Chemotherapy involves using one or more anti-cancer drugs to kill cancer cells.
    • Multi-agent chemotherapy is standard for initial management of high-risk gestational trophoblastic neoplasia (GTN) [5].
    • The most common drug regimen is EMA-EP; resistant disease may be controlled with surgical resection [6].
  • Surgery: Surgery may be necessary to remove the tumor or to control symptoms.
    • Surgical resection can be used to control resistant disease [6].
  • Radiation therapy: This treatment uses high-energy rays to kill cancer cells. However, it is not commonly used for trophoblastic neoplasms.

Chemotherapy Drugs Used

The following chemotherapy drugs are commonly used to treat trophoblastic neoplasms:

  • Dactinomycin (Cosmegen): This drug is often used as a first-line treatment for GTN [2].
  • Methotrexate Sodium (Trexall): This drug is also commonly used to treat GTN, especially in combination with other medications [2].

Treatment Outcomes

The prognosis for trophoblastic neoplasms is generally good, especially if treated promptly. With modern treatment options, the cure rate for GTN is high.

  • High-risk cases: Multi-agent chemotherapy can be effective in treating high-risk cases of GTN [5].
  • Recurrent disease: Treatment outcomes are generally good even in recurrent cases, with a low risk of secondary tumors [3].

References

[1] - The main treatment for invasive mole and choriocarcinoma is chemotherapy. Some women might have immunotherapy drugs [8]. [2] - Oct 23, 2020 — Drugs Approved for Gestational Trophoblastic Disease [2] [3] - Treatment outcomes are generally good even in recurrent cases, with a low risk of secondary tumors [3]. [5] - Multi-agent chemotherapy is standard for initial management of high-risk gestational trophoblastic neoplasia (GTN) [5]. [6] - The most common drug regimen is EMA-EP; resistant disease may be controlled with surgical resection [6] [8] - The main treatment for invasive mole and choriocarcinoma is chemotherapy. Some women might have immunotherapy drugs [8].

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnoses of Trophoblastic Neoplasms

Trophoblastic neoplasms, a subset of gestational trophoblastic disease (GTD), can be challenging to diagnose due to their varied presentations. The following conditions are considered in the differential diagnosis of trophoblastic neoplasms:

  • Hydatidiform mole: A benign condition characterized by abnormal fertilization events, which can mimic the presentation of a molar pregnancy.
  • Choriocarcinoma: A malignant tumor that forms inside a pregnant woman's uterus, often presenting with vaginal bleeding and elevated human chorionic gonadotropin (hCG) levels.
  • Invasive mole: A type of trophoblastic neoplasia characterized by the growth of trophoblast cells into the muscle layer of the uterus.
  • Placental site trophoblastic tumor (PSTT): A rare and malignant tumor that arises from the placenta, often presenting with vaginal bleeding and elevated hCG levels.
  • Epithelioid trophoblastic tumor (ETT): A rare and malignant tumor that can coexist with other trophoblastic neoplasms.

Key Features to Consider

When considering the differential diagnosis of trophoblastic neoplasms, the following key features should be taken into account:

  • Histological findings: The presence of villi or absence of fetal parts in the uterus.
  • Cytological atypia and mitotic figures: Significant cytological atypia and mitotic figures may be seen in complete moles.
  • Elevated hCG levels: Elevated human chorionic gonadotropin (hCG) levels are often present in trophoblastic neoplasms.

Clinical Presentation

Trophoblastic neoplasms can present with a range of symptoms, including:

  • Vaginal bleeding
  • Abdominal pain
  • Neurological signs from spine or brain metastasis

It is essential to consider these differential diagnoses in patients presenting with unusual presentations and serum hCG should be performed as part of the workup.

References: * NCCN Guidelines for Gestational Trophoblastic Neoplasia * GTD (Gestational Trophoblastic Disease) - A spectrum of disorders from pre-malignant conditions to malignant invasive mole, choriocarcinoma and rare placental site trophoblastic tumour/epithelioid trophoblastic tumour (PSTT/ETT).

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:4085
core#notation
DOID:4085
oboInOwl#hasDbXref
UMLS_CUI:C0041182
IAO_0000115
A germ cell and embryonal cancer that derives_from trophoblastic tissue.
rdf-schema#label
trophoblastic neoplasm
oboInOwl#hasExactSynonym
Trophoblastic tumor
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_4084
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
owl#equivalentClass
t427572
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_10691
owl#annotatedSource
t427677

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.